FDA | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

Rebecca Urena06/28/202106/28/2021

3784

On Friday, the U.S. Food and Drug Administration added a warning to Moderna and Pfizer-BioNTech Covid-19 vaccines regarding a rare risk of heart inflammation. Pfizer and Moderna’s fact sheets...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) Drug Designation for Cinrebafusp Alfa

financial buzz06/24/2021

1941

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Pieris Pharmaceuticals, Inc. Receives Orphan Drug Designation for Cinrebafusp Alfa” Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) climbed over 5%...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Novan, Inc. (NASDAQ: NOVN) Surges Upon Announcement of Positive Preclinical Data

financial buzz06/11/2021

1823

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Novan, Inc. Surges Upon Announcement of Positive Preclinical Data” Novan, Inc. (NASDAQ: NOVN) surged over 60% in premarket...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Moderna Requests FDA Approval to Vaccinate Kids 12 to 17

Rebecca Urena06/10/202106/10/2021

3211

Moderna (NASDAQ: MRNA), an American pharmaceutical and biotechnology company, has requested that the Food and Drug Administration grant it emergency use of its Covid-19 vaccine in kids ages 12...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Biogen Receives FDA Approval for Alzheimer’s Drug

Rebecca Urena06/07/202106/07/2021

2619

On Monday, The Food and Drug Administration, approved Biogen’s (NASDAQ: BIIB) Alzheimer’s disease drug aducanumab. The medication, which delays the cognitive decline in patients with Alzheimer’s, is the first...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Moderna Applies for Full FDA Approval of its COVID-19 Vaccine

Rebecca Urena06/01/202106/01/2021

3001

Moderna (NASDAQ: MRNA), an American pharmaceutical, announced it has applied for full approval from the Food and Drug Administration for its Covid-19 vaccine. It is the second U.S. drugmaker...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Iterum Therapeutics (NASDAQ: ITRM) Provides Update on FDA Review

financial buzz05/28/202105/28/2021

2104

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Iterum Therapeutics Surges Following FDA Late-Cycle Meeting” Iterum Therapeutics plc (NASDAQ: ITRM) surged over 17% in premarket trading...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

FDA Advisory Votes on Benefits of the Teplizumab to Outweigh Risks in Support of Approval to Delay Clinical Type 1 Diabetes

Andy Liao05/28/2021

2986

Provention Bio, Inc. (NASDAQ: PRVB) reported that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration voted 10 yes and 7 no on the...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Larimar Therapeutics FDA Clinical Hold on CTI-1601 and Termination of Recent Financing

David Kim05/26/2021

2827

Larimar Therapeutics, Inc. (NASDAQ: LRMR) has reported that the U.S. FDA has placed a clinical hold on the CTI-1601 clinical program and the company will not close its previously...

Biotechnology Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

Scopus BioPharma Reports FDA Approval of IND Application for Drug Candidate in Cancer Treatment

Bryan Shin05/24/2021

3473

Scopus BioPharma Inc. (NASDAQ: SCPS) has reported approval of an investigational new drug application by the U.S. FDA for CpG-STAT3siRNA, the immune-oncology RNA therapy to treat multiple cancers. Phase...

Tag: FDA

FDA adds Heart Inflammation Warning on Pfizer & Moderna Covid Vaccines

“The Buzz” Show: Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) Drug Designation for Cinrebafusp Alfa

“The Buzz” Show: Novan, Inc. (NASDAQ: NOVN) Surges Upon Announcement of Positive Preclinical Data

Moderna Requests FDA Approval to Vaccinate Kids 12 to 17

Biogen Receives FDA Approval for Alzheimer’s Drug

Moderna Applies for Full FDA Approval of its COVID-19 Vaccine

“The Buzz” Show: Iterum Therapeutics (NASDAQ: ITRM) Provides Update on FDA Review

FDA Advisory Votes on Benefits of the Teplizumab to Outweigh Risks in Support of Approval to Delay Clinical Type 1 Diabetes

Larimar Therapeutics FDA Clinical Hold on CTI-1601 and Termination of Recent Financing

Scopus BioPharma Reports FDA Approval of IND Application for Drug Candidate in Cancer Treatment

ABOUT US

Tweets